FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marianne Canonico

Research Profile

Physiology

Postmenopause

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Geneviève Plu-Bureau; Justine Hugon-Rodin; Lorraine Maitrot-Mantelet; Marianne Canonico
Hormonal contraceptives and arterial disease: an epidemiological update.
Geneviève Plu-Bureau; Justine Hugon-Rodin; Lorraine Maitrot-Mantelet; Marianne Canonico
Hormonal contraceptives and venous thromboembolism: an epidemiological update.
Marianne Canonico; Laure Carcaillon; Pascale Gaussem; Anne Guiochon-Mantel; Olivier Rouaud; Joanne Ryan; Sylvie Brailly-Tabard; Julie Setiao; Pierre-Yves Scarabin
Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population-based study (the Three-City cohort study).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marianne Canonico (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Geneviève Plu-Bureau; Justine Hugon-Rodin; Lorraine Maitrot-Mantelet; Marianne Canonico
Hormonal contraceptives and arterial disease: an epidemiological update.
Best practice & research. Clinical endocrinology & metabolism 2013;27(1):35-45.
2013: Geneviève Plu-Bureau; Justine Hugon-Rodin; Lorraine Maitrot-Mantelet; Marianne Canonico
Hormonal contraceptives and venous thromboembolism: an epidemiological update.
Best practice & research. Clinical endocrinology & metabolism 2013;27(1):25-34.
2012: Marianne Canonico; Laure Carcaillon; Pascale Gaussem; Anne Guiochon-Mantel; Olivier Rouaud; Joanne Ryan; Sylvie Brailly-Tabard; Julie Setiao; Pierre-Yves Scarabin
Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population-based study (the Three-City cohort study).
Clinical endocrinology 2012;77(6):905-10.
2012: Valérie Scarabin-Carré; Séverine Trabado; Sylvie Brailly-Tabard; Marianne Canonico; Pierre Ducimetière; Maurice Giroud; Anne Guiochon-Mantel; Catherine Helmer; Geneviève Plu-Bureau; Joanne Ryan; Pierre-Yves Scarabin
High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the three-city cohort study.
Journal of the American Heart Association 2012;1(3):e001388.
2012: Joanne Ryan; Jaqueline Scali; Pierre-Yves Scarabin; Marianne Canonico; Laure Carcaillon; Isabelle Carrière; Jean-Francois Dartigues; carole dufouil; Karen Ritchie; Marie Laure Ancelin
Hormone treatment, estrogen receptor polymorphisms and mortality: a prospective cohort study.
PloS one 2012;7(3):e34112.
2011: Marianne Canonico; Geneviève Plu-Bureau; Pierre-Yves Scarabin
Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.
Maturitas 2011;70(4):354-60.
2011: Marianne Canonico; Pierre-Yves Scarabin
Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.
Menopause (New York, N.Y.) 2011;18(10):1038-9.
2011: Valérie Olié; Geneviève Plu-Bureau; Marianne Canonico; Jacqueline Conard; Marie-Hélène Horellou; Pierre-Yves Scarabin
Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
Menopause (New York, N.Y.) 2011;18(5):488-93.
2011: Valérie Olié; Geneviève Plu-Bureau; Marianne Canonico; Pierre-Yves Scarabin
Risk assessment for recurrent venous thrombosis.
Lancet 2011;377(9771):1072; author reply 1073-4.
2011: Valérie Olié; Marianne Canonico; Pierre-Yves Scarabin
Postmenopausal hormone therapy and venous thromboembolism.
Thrombosis research 2011;127 Suppl 3():S26-9.
2010: Marianne Canonico; Martine Alhenc-Gelas; Geneviève Plu-Bureau; Valérie Olié; Pierre-Yves Scarabin
Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen.
Menopause (New York, N.Y.) 2010;17(6):1122-7.
2010: Valérie Olié; Marianne Canonico; Pierre-Yves Scarabin
Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.
Current opinion in hematology 2010;17(5):457-63.
2010: Marianne Canonico; Agnès Fournier; Laure Carcaillon; Valérie Olié; Geneviève Plu-Bureau; Emmanuel Oger; Sylvie Mesrine; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Pierre-Yves Scarabin
Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(2):340-5.
2008: Marianne Canonico; Geneviève Plu-Bureau; Gordon D O Lowe; Pierre-Yves Scarabin
Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.
BMJ (Clinical research ed.) 2008;336(7655):1227-31.
2008: Marianne Canonico; Valérie Olié; Laure Carcaillon; Pascale Tubert-Bitter; Pierre-Yves Scarabin
Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
Thrombosis and haemostasis 2008;99(1):246-8.
2007: Marianne Canonico; Emmanuel Oger; Geneviève Plu-Bureau; Jacqueline Conard; Guy Meyer; Hervé Lévesque; Nathalie Trillot; Marie-Thérèse Barrellier; Denis Wahl; Joseph Emmerich; Pierre-Yves Scarabin
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Circulation 2007;115(7):840-5.
2006: Marianne Canonico; Céline Straczek; Emmanuel Oger; Geneviève Plu-Bureau; Pierre-Yves Scarabin
Postmenopausal hormone therapy and cardiovascular disease: an overview of main findings.
Maturitas 2006;54(4):372-9.
2006: Marianne Canonico; Emmanuel Oger; Jacqueline Conard; Guy Meyer; H Lévesque; Nathalie Trillot; Marie-Thérèse Barrellier; Denis Wahl; Joseph Emmerich; Pierre-Yves Scarabin
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
Journal of thrombosis and haemostasis : JTH 2006;4(6):1259-65.